Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Jun Chen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Gastroenterology|April 10, 2026
Topical tranexamic acid and sucralfate prevent delayed bleeding after endoscopic sphincterotomy: a randomized controlled trial (with video)Hsueh-Chien Chiang, Jui-Wen Kang, Wei-Lun Chang, et al.
Intestinal Research|November 25, 2025
Evolution of surgical trends in Crohn's disease during the biologic era: population-based cohort insights from Taiwan, a low-endemicity regionEr-Hsiang Yang, Nai-Yu Chen, Ching-Lan Cheng, et al.
Eclinicalmedicine|March 19, 2024
10-Day versus 14-day bismuth quadruple therapy for first-line eradication of <i>Helicobacter pylori</i> infection: a randomised, open-label, non-inferiority trialEr-Hsiang Yang, Wei-Ying Chen, Hsueh-Chien Chiang, et al.
Clinical and Translational Gastroenterology|March 20, 2026
Endoscopic application of tranexamic acid and sucralfate in upper gastrointestinal bleeding: A randomized controlled trialMeng-Hsuan Lu, Hsueh-Chien Chiang, Er-Hsiang Yang, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2021
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosisHong-Ming Tsai, Meng-Zhi Han, Yih-Jyh Lin, et al.
Inflammatory Bowel Diseases|August 31, 2023
Relationship Between Rectal Swab and Tissue Samples in Mucosa-associated Microbiota in Patients With Inflammatory Bowel DiseaseTsunglin Liu, Cheng-Han Lin, Yi-Lin Chen, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in TaiwanJuei-Seng Wu, Tzu-Chun Hong, Hung-Tsung Wu, et al.
Pharmaceutics|November 11, 2022
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular CarcinomaHsin-Yu Kuo, Meng-Zhi Han, Chih-Hsiang Liao, et al.
Therapeutic Advances in Medical Oncology|January 13, 2025
Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settingsChien-Ming Chiang, Kuan-Kai Huang, Chun-Te Lee, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Gastroenterology|April 10, 2026
Topical tranexamic acid and sucralfate prevent delayed bleeding after endoscopic sphincterotomy: a randomized controlled trial (with video)Hsueh-Chien Chiang, Jui-Wen Kang, Wei-Lun Chang, et al.
Intestinal Research|November 25, 2025
Evolution of surgical trends in Crohn's disease during the biologic era: population-based cohort insights from Taiwan, a low-endemicity regionEr-Hsiang Yang, Nai-Yu Chen, Ching-Lan Cheng, et al.
Eclinicalmedicine|March 19, 2024
10-Day versus 14-day bismuth quadruple therapy for first-line eradication of <i>Helicobacter pylori</i> infection: a randomised, open-label, non-inferiority trialEr-Hsiang Yang, Wei-Ying Chen, Hsueh-Chien Chiang, et al.
Clinical and Translational Gastroenterology|March 20, 2026
Endoscopic application of tranexamic acid and sucralfate in upper gastrointestinal bleeding: A randomized controlled trialMeng-Hsuan Lu, Hsueh-Chien Chiang, Er-Hsiang Yang, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2021
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosisHong-Ming Tsai, Meng-Zhi Han, Yih-Jyh Lin, et al.
Inflammatory Bowel Diseases|August 31, 2023
Relationship Between Rectal Swab and Tissue Samples in Mucosa-associated Microbiota in Patients With Inflammatory Bowel DiseaseTsunglin Liu, Cheng-Han Lin, Yi-Lin Chen, et al.
Journal of Gastrointestinal Oncology|May 18, 2023
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in TaiwanJuei-Seng Wu, Tzu-Chun Hong, Hung-Tsung Wu, et al.
Pharmaceutics|November 11, 2022
Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular CarcinomaHsin-Yu Kuo, Meng-Zhi Han, Chih-Hsiang Liao, et al.
Therapeutic Advances in Medical Oncology|January 13, 2025
Comparing immunotherapy effectiveness for unresectable hepatocellular carcinoma: infiltrative versus non-infiltrative types in real-world settingsChien-Ming Chiang, Kuan-Kai Huang, Chun-Te Lee, et al.
Cancers|February 11, 2023
Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular CarcinomaHsueh-Chien Chiang, Yang-Cheng Lee, Ting-Tsung Chang, et al.
Pageof 3